Viral chemokine-binding proteins

Journal of Leukocyte Biology

Volumn 72, Issue 1, 2002, Pages 24-34

  Seet, Bruce T ^a,b   McFadden, Grant ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Chemokine antagonist; Chemokine receptor; CKBP; Herpesvirus; Poxvirus; vCCI; Viral chemokine inhibitor; Viral immune evasion

Indexed keywords

BINDING PROTEIN; CHEMOKINE BINDING PROTEIN; CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

BINDING COMPETITION; CELL MIGRATION; DNA VIRUS; HERPES VIRUS; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFECTION; INFLAMMATION; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; TARGET CELL;

AMINO ACID SEQUENCE; ANIMALS; CHEMOKINES; CHEMOKINES, CC; GLYCOSAMINOGLYCANS; HERPESVIRIDAE; INFLAMMATION; MICE; MOLECULAR SEQUENCE DATA; POXVIRIDAE; RECEPTORS, INTERFERON; SEQUENCE ALIGNMENT; VIRAL PROTEINS;

DNA VIRUSES; HERPESVIRIDAE; POXVIRIDAE;

EID: 0036659118     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Alcami, A., Koszinowski, U. H. (2000) Viral mechanisms of immune evasion. Immunol. Today 8, 447-455.
2. McFadden, G. (2000) Virus "Star Wars." Science and Medicine 7, 38-47.
3. Lalani, A. S., Barrett, J., McFadden, G. (2000) Modulating chemokines: more lessons from viruses. Immunol. Today 21, 100-106.
4. Murphy, P. M. (2001) Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2, 116-122.
5. Smith, G. L., Symons, J. A., Khanna, A., Vanderplasschen, A., Alcami, A. (1997) Vaccinia virus immune evasion. Immunol. Rev. 159, 137-154.
6. McFadden, G., Schreiber, M., Sedger, L. (1997) Myxoma T2 protein as a model for poxvirus encoded TNF receptor homologs. J. Neuroimmunol. 72, 119-126.
7. Davis-Poynter, N. J., Farrell, H. E. (1996) Masters of deception: a review of herpesvirus immune evasion strategies. Immunol. Cell Biol. 74, 513-522.
8. Wall, E. M., Cao, J. X., Upton, C. (1998) Subversion of cytokine networks by viruses. Int. Rev. Immunol. 17, 121-155.
9. Miller, D. M., Cebulla, C. M., Rahill, B. M., Sedmak, D. D. (2001) Cytomegalovirus and transcriptional down-regulation of major histocompatibility complex class II expression. Semin. Immunol. 13, 11-18.
10. McFadden, G., Murphy, P. M. (2000) Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr. Opin. Microbiol. 3, 371-378.
11. Rosenkilde, M. M., Waldhoer, M., Luttichau, H. R., Schwartz, T. W. (2001) Virally encoded 7TM receptors. Oncogene 20, 1582-1593.
12. Lusso, P. (2000) Chemokines and viruses: the dearest enemies. Virology 273, 228-240.
13. Baggiolini, M., Dewald, B., Moser, B. (1997) Human chemokines: an update. Annu. Rev. Immunol. 15, 675-705.
14. Luster, A. D. (1998) Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338, 436-445.
15. Rollins, B. J. (1997) Chemokines. Blood 90, 909-928.
16. Ward, S. G., Westwick, J. (1998) Chemokines: understanding their role in T-lymphocyte biology. Biochem. J. 333, 457-470.
17. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A. (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176.
18. Huang, H., Li, F., Cairns, C. M., Gordon, J. R., Xiang, J. (2001) Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin. Biochem. Biophys. Res. Comm. 281, 378-382.
19. Kelner, G. S., Kennedy, J., Bacon, K. B., Kleyensteuber, S., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., Bazan, J. F., Moore, K. W., Schall, T. J. (1994) Lymphotactin: a cytokine that represents a new class of chemokine. Science 266, 1395-1399.
20. Yoshida, T., Imai, T., Kakizaki, M., Nishimura, M., Takagi, S., Yoshie, O. (1998) Identification of single C motif-1/lymphotactin receptor XCR1. J. Biol. Chem. 273, 16551-16554.
21. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., Schall, T. J. (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640-644.
22. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., Yoshie, O. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521-530.
23. Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., Zako, M. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777.
24. Witt, D. P., Lander, A. D. (1994) Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4, 394-400.
25. Webb, L. M., Ehrengruber, M. U., Clark-Lewis, I., Baggiolini, M., Rot, A. (1993) Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90, 7158-7162.
26. Patel, D. D., Koopmann, W., Imai, T., Whichard, L. P., Yoshie, O., Krangel, M. S. (2001) Chemokines have diverse abilities to form solid phase gradients. Clin. Immunol. 99, 43-52.
27. Springer, T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314.
28. Martin, L., Blanpain, C., Garnier, P., Wittamer, V., Parmentier, M., Vita, C. (2001) Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry 40, 6303-6318.
29. Tanaka, Y., Kimata, K., Wake, A., Mine, S., Morimoto, I., Yamakawa, N., Habuchi, H., Ashikari, S., Yamamoto, H., Sakurai, K., Yoshida, K., Suzuki, S., Eto, S. (1996) Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells. J. Exp. Med. 184, 1987-1997.
30. Ali, S., Palmer, A. C. V., Banerjee, B., Fritchley, S. J., Kirby, J. A. (2000) Examination of the function of RANTES, MIP-1α, and MIP-1β following interaction with heparin-like glycosaminoglycans. J. Biol. Chem. 275, 11721-11727.
31. Ali, S., Palmer, A. C., Fritchley, S. J., Maley, Y., Kirby, J. A. (2001) Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis. Biochem. J. 358, 737-745.
32. Skelton, N. J., Quan, C., Reilly, D., Lowman, H. (1999) Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure 7, 157-168.
33. Hoogewerf, A., Kuschert, G. S. V., Proudfoot, A. E., Borlat, F., Clark-Lewis, I., Power, C. A., Wells, T. N. C. (1997) Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36, 13570-13578.
34. McFadden, G., Kelvin, D. (1997) New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road. Biochem. Pharmacol. 54, 1271-1280.
35. Chee, M. S., Satchwell, S. C., Preddie. E., Weston, K. M., Barrell, B. G. (1990) Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 344, 774-777.
36. Lee, H. J., Essani, K., Smith, G. L. (2001) The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology 281, 170-192.
37. Tulman, E. R., Afonso, C. L., Lu, Z., Zsak, L., Kutish, G. F., Rock, D. L. (2001) Genome of lumpy skin disease virus. J. Virol. 75, 7122-7130.
38. Cao, J. X., Gershon, P. D., Black, D. N. (1995) Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. Virology 209, 207-212.
39. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Kutish, G. F., Rock, D. L. (2000) The genome of fowlpox virus. J. Virol. 74, 3815-3831.
40. Lalani, A. S., Graham, K., Mossman, K., Rajarathnam, K., Clark-Lewis, I., Kelvin, D., McFadden, G. (1997) The purified myxoma virus IFN-γ receptor homolog, M-T7, interacts with the heparin binding domains of chemokines. J. Virol. 71, 4356-4363.
41. Liu, L. Y., Lalani, A., Dai, E., Seet, B., Macauley, C., Singh, R., Fan, L., McFadden, G., Lucas, A. (2000) The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J. Clin. Investig. 105, 1613-1621.
42. Graham, K. A., Lalani, A. S., Macen, J. L., Ness, T. L., Barry, M., Liu, L-Y., Lucas, A., Clark-Lewis, I., Moyer, R. W., McFadden, G. (1997) The T1/35 kDa family of poxvirus secreted proteins bind chemokines and modulate leukocyte influx into virus infected tissues. Virology 229, 12-24.
43. Lalani, A. S., Ness, T. L., Singh, R., Harrison, J. K., Seet, B. T., Kelvin, D. J., McFadden, G., Moyer, R. W. (1998) Functional comparisons among members of the poxvirus T1/35 kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology 250, 173-184.
44. Lalani, A. S., Masters, J., Graham, K., Liu, L., Lucas, A., McFadden, G. (1999) Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology 256, 233-245.
45. Seet, B. T., Barrett, J., Robichaud, J., Shilton, B., Singh, R., McFadden, G. (2001) Glycosaminoglycan-binding properties of the myxoma virus CC-chemokine inhibitor, M-T1. J. Biol. Chem. 276, 30504-30513.
46. Martinez-Pomares, L., Thompson, J. P., Moyer, R. W. (1995) Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. Virology 206, 591-600.
47. Smith, C. A., Smith, T. D., Smolak, P. J., Friend, D., Hagen, H., Gerhart, M., Park, L., Pickup, D. J., Torrance, D., Mohler, K., Schooley, K., Goodwin, R. G. (1997) Poxvirus genomes encode a secreted soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236, 316-327.
48. Alcamí, A., Symons, J. A., Collins, P. D., Williams, T. J., Smith, G. L. (1998) Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160, 624-633.
49. Carfi, A., Smith, C. A., Smolak, P. J., McGrew, J., Wiley, D. C. (1999) Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc. Natl. Acad. Sci. USA 96, 12379-12383.
50. Dabbagh, K., Xiao, Y., Smith, C., Stepick-Biek, P., Kim, S. G., Lamm, W. J., Liggitt, D. H., Lewis, D. B. (2000) Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI. J. Immunol. 165, 3418-3422.
51. Patel, A. H., Gaffney, D. F., Subak-Sharpe, J. H., Stow, N. D. (1990) DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister. J. Gen. Virol. 71, 2013-2021.
52. Seet, B. T., Singh, R., Paavola, C., Lau, E. K., Handel, T. M., McFadden, G. (2001) Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc. Natl. Acad. Sci. USA 98, 9008-9013.
53. Beck, C. G., Studer, C., Zuber, J. F., Jachez Demange, B., Manning, U., Urfer, R. (2001) The viral CC chemokine binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B binding site. J. Biol. Chem. 276, 43270-43276.
54. Burns, J. M., Dairaghi, D. J., Schall, T. J. (2001) Comprehensive mapping of poxvirus vCCI chemokine binding protein: expanded range of ligand interactions and unusual dissociation kinetics. J. Biol. Chem. 277, 2785-2789.
55. Smith, V. P., Alcamí, A. (2000) Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. J. Virol. 74, 8460-8471.
56. Parry, C. M., Simas, J. P., Smith, V. P., Stewart, C. A., Minson, A. C., Efstathiou, S., Alcami, A. (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191, 573-578.
57. van Berkel, V., Barrett, J., Tiffany, H. L., Fremont, D. H., Murphy, P. M., McFadden, G., Speck, S. H., Virgin, H. W. (2000) Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74, 6741-6747.
58. van Berkel, V., Preiter, K., Virgin, H. W., Speck, S. H. (1999) Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein. J. Virol. 73, 4524-4529.
59. Simas, J. P., Swann, D., Bowden, R., Efstathiou, S. (1999) Analysis of murine gammaherpesvirus-68 transcription during lytic and latent infection. J. Gen. Virol. 80, 75-82.
60. Bridgeman, A., Stevenson, P. G., Simas, J. P., Efstathiou, S. (2001) A secreted chemokine binding protein encoded by murine gammaherpes-virus-68 is necessary for the establishment of a normal latent load. J. Exp. Med. 194, 301-312.
61. Lalani, A. S., McFadden, G. (1997) Secreted poxvirus chemokine binding proteins. J. Leukoc. Biol. 62, 570-576.
62. Fenner, F., Ratcliffe, F. N. (1965) Myxomatosis. Cambridge, UK, Cambridge University Press.
63. Upton, C., Mossman, K., McFadden, G. (1992) Encoding of a homolog of the interferon-γ receptor by myxoma virus. Science 258, 1369-1372.
64. Mossman, K., Upton, C., Buller, R. M., McFadden, G. (1995) Species specificity of ectromelia virus and vaccinia virus interferon-γ binding proteins. Virology 208, 762-769.
65. Mossman, K., Nation, P., Macen, J., Garbutt, M., Lucas, A., McFadden, G. (1996) Myxoma virus M-T7, a secreted homolog of the interferongamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 215, 17-30.
66. Hemmerich, S., Paavola, C., Bloom, A., Bhakta, S., Freedman, Grunberger, D., Krstenansky, J., Lee, S., McCarley, D., Mulkins, M., Wong, B., Pease, J., Mizoue, L., Mirzadegan, T., Polsky, I., Thompson, K., Handel, T. M., Jarnagin, K. (1999) Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2, Biochem. 38, 13013-13025.
67. Myers, S. J., Wong, L. M., Charo, I. F. (1995) Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells. J. Biol. Chem. 270, 5786-5792.
68. Han, K. H., Green, S. R., Tangirala, R. K., Tanaka, S., Quehenberger, O. (1999) Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling. J. Biol. Chem. 274, 32055-32062.
69. Chakravarty, L., Rogers, L., Quach, T., Breckenridge, S., Kolattukudy, P. E. (1998) Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J. Biol. Chem. 273, 29641-29647.
70. Pakianathan, D. R., Kuta, E. G., Artis, D. R., Skelton, N. J., Hebert, C. A. (1997) Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. Biochemistry 36, 9642-9648.
71. Mayer, M. R., Stone, M. J. (2001) Identification of receptor binding and activation determinants in the N-terminal and N-loop regions of the CC chemokine eotaxin. J. Biol. Chem. 276, 13911-13916.
72. Laurence, J. S., Blanpain, C., De Leener, A., Parmentier, M., LiWang, P. J. (2001) Importance of basic residues and quaternary structure in the function of mip-1beta: ccr5 binding and cell surface sugar interactions. Biochemistry 40, 4990-4999.
73. Myszka, D. G. (1999) Improving biosensor analysis. J. Mol. Recognit. 12, 279-284.
74. Paavola, C. D., Hemmerich, S., Grunberger, D., Polsky, I., Bloom, A., Freedman, R., Mulkins, M., Bhakta, S., McCarley, D., Wiesent, L., Wong, B., Jarnagin, K., Handel, T. M. (1998) Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J. Biol. Chem. 273, 33157-33165.
75. 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. Biochemistry 35, 6569-6584.
76. Laurence, J. S., Blanpain, C., Burgner, J. W., Parmentier, M., LiWang, P. J. (2000) CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry 39, 3401-3409.
77. Rajarathnam, K., Kay, C. M., Dewald, B., Wolf, M., Baggiolini, M., Clark-Lewis, I., Sykes, B. D. (1997) Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activation. J. Biol. Chem. 272, 1725-1729.
78. Paolini, J. F., Willard, D., Consler, T., Luther, M., Krangel, M. S. (1994) The chemokines IL-8, monocyte chemoattractant protein-1 and I-309 are monomers at physiologically relevant concentrations. J. Immunol. 153, 2704-2717.
79. Damon, I., Murphy, P. M., Moss, B. (1998) Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc. Natl. Acad. Sci. USA 95, 6403-6407.
80. Smith, S. A., Mullin, N. P., Parkinson, J., Shchelkunov, S. N., Totmenin, A. V., Loparev, V. N., Srisatjaluk, R., Reynolds, D. N., Keeling, K. L., Justus, D. E., Barlow, P. N., Kotwal, G. J. (2000) Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74, 5659-5666.
81. Reynolds, D., Keeling, K., Molestina, R., Srisatajluk, R., Butterfield, J. H., Ehringer, W., Justus, D. E., Kotwal, G. (1999) Heparin binding activity of vaccinia virus complement control protein confers additional properties of uptake by mast cells and attachment to endothelial cells. In Advances in Animal Virology (S. Jameel, L. Villareal, eds.), New Delhi, Oxford and IBN Publishing.
82. Alcami, A., Khanna, A., Paul, N. L., Smith, G. L. (1999) Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J. Gen. Virol. 80, 949-959.
83. Alcami, A., Symons, J. A., Smith, G. L. (2000) The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J. Virol. 74, 11230-11239.
84. Colamonici, O. R., Domanski, P., Sweitzer, S. M., Lamer, A., Buller, R. M. (1995) Vaccinia virus B18R gene encodes a type I interferonbinding protein that blocks interferon alpha transmembrane signaling. J. Biol. Chem. 270, 15974-15978.
85. Murthy, K. H., Smith, S. A., Ganesh, V. K., Judge, K. W., Mullin, N., Barlow, P. N., Ogata, C. M., Kotwal, G. J. (2001) Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell 104, 301-311.
86. Virgin 4th, H. W., Latreille, P., Wamsley, P., Hallsworth, K., Weck, K. E., Dal Canto, A. J., Speck, S. H. (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71, 5894-5904.
87. Simas, J. P., Efstathiou, S. (1998) Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol. 6, 276-282.
88. Efstathiou, S., Ho, Y. M., Hall, S., Styles, C. J., Scott, S. D., Gompels, U. A. (1990) Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J. Gen. Virol. 71, 1365-1372.
89. Clambey, E. T., Virgin 4th, H. W., Speck, S. H. (2000) Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 74, 1973-1984.
90. Flano, E., Husain, S. M., Sample, J. T., Woodland, D. L., Blackman, M. A. (2000) Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165, 1074-1081.
91. Usherwood, E. J., Stewart, J. P., Robertson, K., Allen, D. J., Nash, A. A. (1996) Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J. Gen. Virol. 77, 2819-2825.
92. Sunil-Chandra, N. P., Efstathiou, S., Nash, A. A. (1992) Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73, 3275-3279.
93. Virgin, H. W., Presti, R. M., Li, X. Y., Liu, C., Speck, S. H. (1999) Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J. Virol. 73, 2321-2332.
94. Stevenson, P. G., Belz, G. T., Castrucci, M. R., Altman, J. D., Doherty, P. C. (1999) A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc. Natl. Acad. Sci. USA 96, 9281-9286.
95. Proudfoot, A. E., Power, C. A., Wells, T. N. (2000) The strategy of blocking the chemokine system to combat disease. Immunol. Rev. 177, 246-256.
96. Rothenberg, M. E., Zimmermann, N., Mishra, A., Brandt, E., Birkenberger, L. A., Hogan, S. P., Foster, P. S. (1999) Chemokines and chemokine receptors: their role in allergic airway disease. J. Clin. Immunol. 19, 250-265.
97. Yuan, G. H., Masuko-Hongo, K., Sakata, M., Tsuruha, J., Onuma, H., Nakamura, H., Aoki, H., Kato, T., Nishioka, K. (2001) The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum. 44, 1056-1070.
98. Pease, J. E., Williams, T. J. (2001) Eotaxin and asthma. Curr. Opin. Pharmacol. 1, 248-253.
99. Nelson, P. J., Krensky, A. M. (2001) Chemokines and allograft rejection: narrowing the list of suspects. Transplantation 72, 1195-1197.
100. Gerard, C., Rollins, B. J. (2001) Chemokines and disease. Nat. Immunol. 2, 108-115.
101. Murphy, P. M. (2000) Viral antichemokines: from pathogenesis to drug discovery. J. Clin. Investig. 105, 1515-1517.
102. Mossman, K., Upton, C., McFadden, G. (1995) The myxoma virussoluble interferon-γ receptor homolog, M-T7, inhibits interferon-γ in a species-specific manner. J. Biol. Chem. 270, 3031-3038.